Vorinostat Active Not Recruiting Phase 3 Trials for Cutaneous T-Cell Lymphoma (CTCL) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01728805Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL